CALADRIUS BIOSCIENCES INC (CLBS) Stock Analyst Earnings Estimates
NASDAQ:CLBS - Nasdaq - US1280582032 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.94M | 22.49M 25.36% | 32.797M -100.00% | 4.08M | 6.12M 50.00% | 9M 47.06% | 13.5M 50.00% | |||||||
| EBITDA YoY % growth | -55.55M | -48.89M 11.99% | N/A 40.58% | N/A 6.30% | -17.34M 38.42% | N/A -19.48% | -19.686M 4.72% | -31.008M -51.95% | -28.56M 1.50% | -24.174M 15.36% | -24.99M -3.38% | -25.968M -3.91% | -27.523M -5.99% | |
| EBIT YoY % growth | -57.74M | -51.58M 10.67% | -32.696M 42.80% | -27.424M 6.47% | -17.952M 38.44% | -20.37M -18.28% | -20.289M 4.71% | -30.86M -51.74% | -28.56M 1.69% | -27.322M 4.33% | -28.878M -5.70% | -28.119M 2.63% | -27.928M 0.68% | |
| Operating Margin | -321.85% | -229.35% | -99.69% | N/A | N/A | N/A | N/A | N/A | N/A | -669.66% | -471.87% | -312.44% | -206.87% | |
| EPS YoY % growth | -16.90 | -14.80 12.43% | -5.16 64.53% | -2.15 59.43% | -1.79 15.02% | -1.77 -3.31% | -0.83 75.94% | -0.55 -15.56% | -0.43 17.62% | -0.37 14.29% | -0.34 8.33% | -0.37 -9.13% | -0.41 -11.31% |
All data in USD
| Q3 / 22 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | -0.12 -2.00% | -0.12 -11.27% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | -7.242M -4.64% | -7.752M -14.10% |
| EBIT Q2Q % growth | -7.853M -12.71% | -8.252M -20.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -11.56% |
| Q1 2022 Q2Q % growth | -0.07 63.16% | -0.10 | 0.03 | 29.01% |
| Q4 2021 Q2Q % growth | -0.11 60.71% | -0.15 | 0.04 | 25.63% |
| Q3 2021 Q2Q % growth | -0.12 58.62% | -0.15 | 0.03 | 21.57% |
| Q2 2021 Q2Q % growth | -0.10 -120.00% | -0.15 | 0.05 | 32.39% |
| Q1 2021 Q2Q % growth | -0.19 50.00% | -0.09 | -0.10 | -119.15% |
| Q4 2020 Q2Q % growth | -0.28 40.43% | -0.26 | -0.02 | -8.36% |
| Q3 2020 Q2Q % growth | -0.29 38.30% | -0.30 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | 0.50 202.04% | -0.40 | 0.90 | 226.50% |
| Q1 2020 Q2Q % growth | -0.38 13.64% | -0.30 | -0.08 | -28.47% |
| Q4 2019 Q2Q % growth | -0.47 | -0.35 | -0.12 | -33.56% |
| Q3 2019 Q2Q % growth | -0.47 | -0.44 | -0.03 | -7.16% |
| Q2 2019 Q2Q % growth | -0.49 | -0.45 | -0.04 | -7.95% |
| Q1 2019 Q2Q % growth | -0.44 | -0.43 | -0.01 | -1.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | 467.843K | -467.843K | -100.00% | |
| Q1 2021 Q2Q % growth | 672.18K | -672.18K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |